504
Participants
Start Date
February 28, 2014
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
Epistem Genedrive® and MolBio Truenat™
S1 will undergo direct smear and Epistem Genedrive® (optional for phase 2\*) testing, before being homogenized with glass beads and split into three portions for testing with Epistem Genedrive®, MolBio Truenat™ and GeneXpert MTB/Rif® respectively. S2 and S3 will be randomized as to the order of testing using Epistem Genedrive® and MolBio Truenat™.
Johns Hopkins University, Baltimore
Collaborators (1)
Boston Medical Center
OTHER
Johns Hopkins University
OTHER